- Home
- ADAP vs CIA Comparison
ADAP vs CIA Comparison
Compare ADAP & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CIA
- Stock Information
- Founded
- ADAP 2008
- CIA 1969
- Country
- ADAP United Kingdom
- CIA United States
- Employees
- ADAP N/A
- CIA N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- ADAP Health Care
- CIA Finance
- Exchange
- ADAP Nasdaq
- CIA Nasdaq
- Market Cap
- ADAP 212.3M
- CIA 222.9M
- IPO Year
- ADAP 2015
- CIA N/A
- Fundamental
- Price
- ADAP $0.59
- CIA $4.58
- Analyst Decision
- ADAP Strong Buy
- CIA
- Analyst Count
- ADAP 4
- CIA 0
- Target Price
- ADAP $3.16
- CIA N/A
- AVG Volume (30 Days)
- ADAP 2.0M
- CIA 120.2K
- Earning Date
- ADAP 11-13-2024
- CIA 11-07-2024
- Dividend Yield
- ADAP N/A
- CIA N/A
- EPS Growth
- ADAP N/A
- CIA N/A
- EPS
- ADAP N/A
- CIA 0.43
- Revenue
- ADAP $175,041,000.00
- CIA $248,376,000.00
- Revenue This Year
- ADAP $180.15
- CIA N/A
- Revenue Next Year
- ADAP N/A
- CIA $4.17
- P/E Ratio
- ADAP N/A
- CIA $10.57
- Revenue Growth
- ADAP 146.27
- CIA 3.02
- 52 Week Low
- ADAP $0.42
- CIA $1.78
- 52 Week High
- ADAP $2.05
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- ADAP 26.22
- CIA 49.60
- Support Level
- ADAP $0.75
- CIA $4.28
- Resistance Level
- ADAP $0.83
- CIA $5.29
- Average True Range (ATR)
- ADAP 0.07
- CIA 0.28
- MACD
- ADAP -0.01
- CIA -0.09
- Stochastic Oscillator
- ADAP 2.36
- CIA 29.50
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.